New gel aims to stop painful scarring after back surgery

NCT ID NCT07153822

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a new gel called Collabarrier® to see if it can prevent scar tissue from forming after back surgery for herniated discs or spinal stenosis. Sixty-nine adults having their first back surgery were randomly given either the new gel or an existing one. Researchers checked MRI scans and pain levels over six weeks to compare how well each gel worked.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Collagen-based adhesion barrier (Collabarrier®)
What this could lead to
If it works, this gel could reduce painful scar tissue after back surgery, helping patients recover with less pain and better mobility.
What could go wrong
This is a small, early-stage study with only 69 patients. The results may not apply to everyone, and the gel might not work better than existing options.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPIDURAL FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ajou University Hospital

    Seoul, South Korea

  • Asan Medical Center

    Seoul, South Korea

  • Korea University Anam Hospital

    Seoul, South Korea

  • The Catholic University of Korea Eunpyeong St. Mary's Hospital

    Seoul, South Korea

  • The Catholic University of Korea Seoul St. Mary's Hospital

    Seoul, South Korea

  • The Catholic University of Korea St. Vincent's Hospital

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.